Soleno Therapeutics (SLNO) News Today → Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad) Free SLNO Stock Alerts $44.53 -3.11 (-6.53%) (As of 11:32 AM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineSoleno Therapeutics, Inc. (NASDAQ:SLNO) Given Consensus Rating of "Buy" by Analystsmarketbeat.com - May 10 at 9:01 AMSoleno Therapeutics (NASDAQ:SLNO) Coverage Initiated at Robert W. Bairdmarketbeat.com - May 10 at 8:23 AMSLNO Stock Earnings: Soleno Therapeutics Misses EPS for Q1 2024investorplace.com - May 10 at 1:03 AMSoleno Therapeutics’ DCCR Poised for FDA Approval and Blockbuster Sales: An Analyst’s Bullish Outlookmarkets.businessinsider.com - May 9 at 9:25 PMSoleno Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Resultsglobenewswire.com - May 9 at 4:05 PMVivo Capital LLC Increases Stock Holdings in Soleno Therapeutics, Inc. (NASDAQ:SLNO)marketbeat.com - May 9 at 10:39 AMWhile institutions invested in Soleno Therapeutics, Inc. (NASDAQ:SLNO) benefited from last week's 4.8% gain, private equity firms stood to gain the mostfinance.yahoo.com - May 8 at 11:07 AMSoleno Therapeutics (NASDAQ:SLNO) Shares Gap Down to $49.23americanbankingnews.com - May 5 at 3:38 AMVivo Opportunity, Llc Sells 750,000 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO) Stockamericanbankingnews.com - May 3 at 4:04 AMSoleno Therapeutics Prices Public Offering Of 3 Mln Shares At $46/shr; Stock Down In After-hoursnasdaq.com - May 3 at 1:48 AMSoleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering Of Common Stockglobenewswire.com - May 2 at 10:32 PMSoleno Therapeutics Announces Proposed Public Offering of Common Stockglobenewswire.com - May 2 at 4:01 PMSoleno Therapeutics, Inc. (NASDAQ:SLNO) Major Shareholder Vivo Opportunity, Llc Sells 750,000 Sharesinsidertrades.com - May 2 at 5:48 AMSoleno Therapeutics Announces Peer-Reviewed Publication of Data Comparing DCCR Treatment to the Natural History of Prader-Willi Syndromeglobenewswire.com - April 30 at 8:00 AMSoleno Therapeutics Gets Breakthrough Therapy Designation for Diazoxide Cholinemarketwatch.com - April 29 at 4:41 PMSoleno Therapeutics Shares Rise 37% After Breakthrough Designation for Diazoxide Cholinemarketwatch.com - April 29 at 4:41 PMSoleno: Mid-2024 NDA Filing For PWS Treatment Is A Major Catalyst To Watchseekingalpha.com - April 29 at 4:41 PMSoleno Therapeutics (NASDAQ:SLNO) Shares Gap Up to $37.89marketbeat.com - April 29 at 12:11 PMWhy Soleno Therapeutics Stock Is Skyrocketing Todayfool.com - April 29 at 11:11 AMSoleno Therapeutics Receives Breakthrough Therapy Designation from U.S. FDA for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome (PWS)globenewswire.com - April 29 at 8:00 AMSoleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)globenewswire.com - April 19 at 4:05 PMSoleno Therapeutics (NASDAQ:SLNO) Shares Up 3.4%marketbeat.com - April 15 at 2:49 PMCarlyle Group Inc. Acquires 564,242 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO)marketbeat.com - April 14 at 8:45 PMSoleno Therapeutics CEO sells over $780k in company stockinvesting.com - April 5 at 11:15 PMInsider Selling: Soleno Therapeutics, Inc. (NASDAQ:SLNO) Insider Sells 2,218 Shares of Stockinsidertrades.com - April 4 at 6:49 AMInsider Sell: CFO James Mackaness Sells 5,175 Shares of Soleno Therapeutics Inc (SLNO)finance.yahoo.com - April 4 at 3:16 AMCEO Bhatnagar Anish Sells 18,980 Shares of Soleno Therapeutics Inc (SLNO)finance.yahoo.com - April 4 at 3:16 AMSoleno Therapeutics, Inc. (NASDAQ:SLNO) Insider Kristen Yen Sells 2,218 Sharesmarketbeat.com - April 4 at 12:21 AMSoleno Therapeutics, Inc. (NASDAQ:SLNO) Sees Large Increase in Short Interestmarketbeat.com - March 31 at 10:14 PMSoleno Therapeutics (NASDAQ:SLNO) Trading Up 5.6%marketbeat.com - March 26 at 5:13 PMWalleye Capital LLC Takes $1.37 Million Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO)marketbeat.com - March 19 at 4:22 AMSLNO Apr 2024 40.000 putfinance.yahoo.com - March 16 at 10:33 PMSLNO Apr 2024 35.000 putfinance.yahoo.com - March 16 at 7:31 AMSchonfeld Strategic Advisors LLC Acquires Shares of 23,200 Soleno Therapeutics, Inc. (NASDAQ:SLNO)marketbeat.com - March 12 at 5:17 AMConstruction of Soleno's $22M pipe factory in Saratoga underwaybizjournals.com - March 11 at 10:09 AMWe're Not Worried About Soleno Therapeutics' (NASDAQ:SLNO) Cash Burnfinance.yahoo.com - March 11 at 10:09 AMSoleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)globenewswire.com - March 8 at 4:05 PMPiper Sandler Reaffirms Their Buy Rating on Soleno Therapeutics (SLNO)markets.businessinsider.com - March 8 at 7:23 AMSLNO Stock Earnings: Soleno Therapeutics Misses EPS for Q4 2023investorplace.com - March 7 at 12:02 AMSoleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Resultsglobenewswire.com - March 6 at 4:05 PMRA Capital Management L.P. Acquires New Holdings in Soleno Therapeutics, Inc. (NASDAQ:SLNO)marketbeat.com - March 6 at 2:35 PM683 Capital Management LLC Buys New Shares in Soleno Therapeutics, Inc. (NASDAQ:SLNO)marketbeat.com - March 1 at 10:36 AMSoleno Therapeutics (NASDAQ:SLNO) Sets New 1-Year High at $51.49marketbeat.com - February 26 at 10:51 AMSoleno Therapeutics Inc.thestreet.com - February 24 at 10:38 PMSLNO Apr 2024 65.000 callfinance.yahoo.com - February 22 at 9:51 PMSoleno Therapeutics to Present at the TD Cowen 44th Annual Health Care Conferencefinance.yahoo.com - February 22 at 8:41 AMSoleno Therapeutics to Present at the TD Cowen 44th Annual Health Care Conferenceglobenewswire.com - February 22 at 8:00 AMSLNO Mar 2024 40.000 callca.finance.yahoo.com - February 18 at 3:41 PMSLNO Mar 2024 22.500 putfinance.yahoo.com - February 18 at 3:41 PMSilverarc Capital Management LLC Purchases Shares of 370,000 Soleno Therapeutics, Inc. (NASDAQ:SLNO)marketbeat.com - February 18 at 12:53 PM Get Soleno Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SLNO and its competitors with MarketBeat's FREE daily newsletter. Email Address Do This Today BEFORE Biden Wins in November (Ad)Discover "U.S.'s New Money" Before Biden Wins A new form of money has emerged in America, and it's making some folks wildly rich… (Musk and Bezos both use it). Find out how you can too in this free video. SLNO Media Mentions By Week SLNO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SLNO News Sentiment▼1.050.45▲Average Medical News Sentiment SLNO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SLNO Articles This Week▼102▲SLNO Articles Average Week Get Soleno Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SLNO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: InMode News CONMED News BioLife Solutions News Rhythm Pharmaceuticals News Larimar Therapeutics News Edap Tms News FONAR News Rockwell Medical News LivaNova News TransMedics Group News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SLNO) was last updated on 5/10/2024 by MarketBeat.com Staff From Our Partners[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICThis 1 Biotech Stock has been shocking the marketsHuge AlertsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaCharles Payne Demystifies OptionsUnstoppable ProsperityYou need to know these two things about AI stocks ASAP…InvestorPlaceShocking: One AI startup's revenue could surge 4,735%Manward PressHe Is Giving Away BitcoinCrypto Swap Profits[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Soleno Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
